AFC-HD AMS Life Science Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Aug'24
Aug'23
Aug'22
Aug'21
Aug'20
Aug'19
No of Months
12
12
12
12
12
12
Profit Before Tax
1,910.00
1,545.00
1,235.00
2,157.00
1,004.00
1,091.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-812.00
-1,364.00
188.00
71.00
65.00
-76.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,540.00
865.00
1,492.00
2,582.00
1,299.00
1,131.00
Cash Flow from Investing Activities
-2,761.00
-1,946.00
-1,077.00
-274.00
-458.00
-202.00
Cash Flow from Financing Activities
2,232.00
1,881.00
1,159.00
2,185.00
-574.00
-546.00
Net Cash Inflow / Outflow
1,008.00
804.00
1,590.00
4,496.00
268.00
377.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
3.00
16.00
3.00
3.00
-5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of AFC-HD AMS Life Science Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
1910.802
936.687
974.00
104.00%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-812.991
-899.168
87.00
9.58%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1540.093
-189.093
1,729.00
914.46%
Cash Flow from Investing Activities
-2761.467
-108.059
-2,653.00
-2455.52%
Cash Flow from Financing Activities
2232.074
354.838
1,878.00
529.04%
Net Cash Inflow / Outflow
1008.53
57.686
951.00
1648.31%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-2.17
0
-2.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Aug'24
YoY Growth in year ended Aug 2024 is 77.99% vs -42.02% in Aug 2023
Aug'24
Aug'23
Change(%)
Cash Flow from Operating Activities
1,540.09
865.28
77.99%






